Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
20 May 2024
// James Waldron FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/gileads-recently-acquired-liver-disease-med-continues-deliver-goods-ahead-fda-verdict
11 Mar 2024
// BUSINESSWIRE
04 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/03/04/2839523/37067/en/CymaBay-Announces-European-Medicines-Agency-Accepts-for-Review-the-Marketing-Authorization-Application-for-Seladelpar-for-the-Treatment-of-Primary-Biliary-Cholangitis.html
28 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/28/2837495/37067/en/CymaBay-Reports-Fourth-Quarter-and-Year-Ended-December-31-2023-Financial-Results-and-Provides-Corporate-Update.html
26 Feb 2024
// Annalee Armstrong FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/cymabay-board-pushed-50-cent-top-gileads-3250-share-offer
21 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/the-new-england-journal-of-medicine-publishes-positive-phase-3-response-data-of-cymabays-seladelpar-in-primary-biliary-cholangitis-302068089.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?